Effect of PCSK9-Antibody (Alirocumab) on Dyslipidemia Secondary to Nephrotic Syndrome
Clinical trial NCT03004001 · TERMINATED
Trial details
- NCT number
- NCT03004001
- Sponsor
- Gloria Vega
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-01
- Primary completion
- 2019-12-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.